Latest News & Features
Americas
Wearable technology maker Jawbone has accused rival Fitbit of using patent litigation and “poaching” key employees to hurt it commercially in an anti-competition claim filed at a US court. 3 November 2015
Americas
Wearable technology company Fitbit has accused competitor Aliphcom of infringing a number of its patents covering devices that record an individual’s fitness. 2 November 2015
Americas
The US Court of Appeals for the Federal Circuit issued two separate judgments concerning the alleged infringement of a patent covering an access control mechanism for a wireless network by medical device makers Medtronic and St. Jude Medical. 30 October 2015
Americas
US law firm Baker Donelson has expanded its Memphis office by hiring Cong Ding as of counsel in the firm’s intellectual property group. 30 October 2015
Americas
Pharmaceutical company Pfizer has confirmed it has entered into talks with generics company Allergan over a potential merger. 29 October 2015
Big Pharma
The English High Court has affirmed the validity of the Ono Pharmaceutical’s cancer immunotherapy drug after it was challenged by pharmaceutical company Merck. 29 October 2015
Europe
Philip Webber, partner at Dehns Patent & Trademark Attorneys, looks at the clarity of the language used in the Broad Institute of MIT and Harvard’s granted European patents for the CRISPR technology and questions whether it satisfies the European Patent Office’s requirements. 29 October 2015
Americas
Oppositions to a patent covering the CRISPR/Cas9 system illustrate the need for applicants to carefully consider making statements on commercially important technology even after a patent application has been filed. Catherine Coombes of law firm HGF reports. 29 October 2015
Biotechnology
There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics. 28 October 2015
Americas
The Coalition for Affordable Drugs, an organisation closely tied to hedge fund manager Kyle Bass, has persuaded the Patent Trial and Appeal Board to institute an inter partes review concerning the validity of two patents owned by biopharmaceutical company Celgene. 28 October 2015